Stage III Adult Soft Tissue Sarcoma

specific

Stage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. G3: Grade 3. There is no T2a for the pathologic group. (AJCC 7th ed.)

61

Centers

0

Active Trials

Cancer Funding

Top Centers for Stage III Adult Soft Tissue Sarcoma(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
50.8
2
NCI Comprehensive
50.8
3
NCI Comprehensive
50.8
450.8
550.8
6
NCI Comprehensive
50.8
7
NCI Comprehensive
50.8
8
NCI Comprehensive
50.8
9
NCI Comprehensive
50.8
10
NCI Comprehensive
50.8
11
NCI Comprehensive
50.8
1250.8
13
NCI Comprehensive
50.8
14
NCI Comprehensive
50.8
1550.8
1650.8
17
NCI Comprehensive
50.8
18
NCI Comprehensive
50.8
1950.8
20
NCI Comprehensive
50.8
21
NCI Comprehensive
50.8
2250.8
23
NCI Comprehensive
50.8
24
NCI Comprehensive
50.8
2550.8
26
NCI Clinical
50.8
27
NCI Comprehensive
50.8
2850.8
29
Cedars-Sinai CancerLos Angeles, CA
50.8
30
NCI Clinical
50.8
3150.8
32
NCI Comprehensive
50.8
3350.8
3450.8
3550.8
36
NCI Comprehensive
50.8
37
NCI Comprehensive
50.8
3850.8
3950.8
4050.8
4150.8
42
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
50.8
4350.8
44
NCI Comprehensive
50.8
4550.8
4650.8
4750.8
4850.8
4950.8
5050.8
5150.8
5250.8
5350.8
5450.8
5550.8
5650.8
5750.8
5850.8
5950.8
60
BC CancerVancouver, BC
50.8
6150.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →